We also speculated whether the apparent lack of association between CUBN and eGFR in our diabetes meta-analysis could be due to use of Angiotensin receptor blockers (ARBs) or Angiotensin-converting enzyme inhibitor (ACEi) medication which is frequently used in diabetes treatment. Here, CUBN is linked to diabetes mellitus.